The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2017

Filed:

Jun. 16, 2014
Applicant:

Hanmi Pharm. Co., Ltd, Hwaseong-si, Gyeonggi-do, KR;

Inventors:

Ho Taek Im, Yongin-si, KR;

Taek Kwan Kwon, Suwon-si, KR;

Yong Il Kim, Suwon-si, KR;

Jae Hyun Park, Suwon-si, KR;

Jong Soo Woo, Suwon-si, KR;

Assignee:

HANMI PHARM. CO., LTD, Hwaseong-Si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/495 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/1694 (2013.01); A61K 31/47 (2013.01);
Abstract

The present invention relates to a complex granule formulation comprising a first granular part comprising levocetirizine or its pharmaceutically acceptable salt, cyclodextrin or its derivative, and an alkalinizing agent; and a second granular part comprising montelukast or its pharmaceutically acceptable salt, cyclodextrin or its derivative, and an alkalinizing agent. This formulation can effectively inhibit the production of related compounds of levocetirizine and montelukast by allowing levocetirizine and montelukast to form clathrate complexes with cyclodextrin, and using an alkalinizing agent. This formulation not only shows increased stability and bioavailability, but also improves patient compliance owing to its effective masking of bitter taste.


Find Patent Forward Citations

Loading…